Blood cancer journal 2025 Apr 17
Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study.
Related Questions
New answer by at University of Chicago (February 27, 2026)
The management of myelofibrosis with anemia is becoming increasingly nuanced, given the several JAK inhibitors available to us and the potential for add-on therapies! An excel...